Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
The American Journal of Cardiology|February 2, 2008
Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary interventionProbal Roy, Ashesh N Buch, Aamir Javaid, et al.
The American Journal of Cardiology|March 10, 2010
Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomesMichael A Gaglia, Rebecca Torguson, Nicholas Hanna, et al.
Cancer Research|April 28, 2017
tRF/miR-1280 Suppresses Stem Cell-like Cells and Metastasis in Colorectal CancerBingqing Huang, Huipeng Yang, Xixi Cheng, et al.
The American Journal of Cardiology|February 7, 2009
Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stentsDaniel H Steinberg, Michael A Gaglia, Tina L Pinto Slottow, et al.
The American Journal of Cardiology|January 28, 2010
Safety and in-hospital outcomes of bivalirudin use in dialysis patients undergoing percutaneous coronary interventionCedric Delhaye, Gabriel Maluenda, Kohei Wakabayashi, et al.
Circulation. Cardiovascular Interventions|April 13, 2012
Impact of drug-eluting stents on distal vesselsKohei Wakabayashi, Gary S Mintz, Neil J Weissman, et al.
The American Journal of Cardiology|March 4, 2008
Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristicsAamir Javaid, Nauman H Siddiqi, Daniel H Steinberg, et al.
Nature Communications|July 15, 2021
Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarizationLijuan Zhang, Kai Zhang, Jieyou Zhang, et al.
The American Journal of Cardiology|August 10, 2010
Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry)Nicholas N Hanna, Michael A Gaglia, Rebecca Torguson, et al.
Oncotarget|October 21, 2016
Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen productionHuafeng Wang, Huan Zhang, Yuqing Zhang, et al.
Pageof 19